NeuroPace (NPCE) Short Interest Ratio & Short Volume → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free NPCE Stock Alerts $8.50 +0.53 (+6.65%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media NeuroPace Short Interest DataCurrent Short Volume89,800 sharesPrevious Short Volume97,100 sharesChange Vs. Previous Month-7.52%Dollar Volume Sold Short$1.17 millionShort Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares28,770,000 sharesFloat Size13,740,000 sharesShort Percent of Float0.65%Today's Trading Volume336,451 sharesAverage Trading Volume117,894 sharesToday's Volume Vs. Average285% Short Selling NeuroPace ? Sign up to receive the latest short interest report for NeuroPace and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNPCE Short Interest Over TimeNPCE Days to Cover Over TimeNPCE Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide NeuroPace Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202489,800 shares $1.17 million -7.5%0.7%0.8 $12.99 4/15/202497,100 shares $1.30 million +13.0%0.7%0.9 $13.40 3/31/202485,900 shares $1.13 million +178.0%0.7%0.9 $13.20 3/15/202430,900 shares $407,262.00 -38.6%0.3%0.3 $13.18 2/29/202450,300 shares $813,351.00 -19.8%0.4%0.6 $16.17 2/15/202462,700 shares $1.01 million -0.5%0.6%0.7 $16.08 Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 1/31/202463,000 shares $921,060.00 +76.0%0.6%0.8 $14.62 1/15/202435,800 shares $410,626.00 -43.6%0.3%0.4 $11.47 12/31/202363,500 shares $654,685.00 -32.5%0.6%0.9 $10.31 12/15/202394,100 shares $852,546.00 -26.9%0.9%1.6 $9.06 11/30/2023128,800 shares $1.16 million -14.7%1.2%2.2 $8.99 11/15/2023151,000 shares $1.31 million -61.8%1.4%2.2 $8.70 10/31/2023395,600 shares $2.67 million +26.4%3.7%4.5 $6.75 10/15/2023313,100 shares $1.88 million +2.0%3.0%3.9 $6.01 9/30/2023307,100 shares $2.99 million -12.8%2.9%4.1 $9.73 9/15/2023352,200 shares $3.05 million -20.2%3.3%4.9 $8.66 8/31/2023441,100 shares $4.14 million -7.8%4.3%6.7 $9.39 8/15/2023478,400 shares $2.15 million +1.3%4.6%14.2 $4.50 7/31/2023472,400 shares $1.96 million +0.5%4.7%26.1 $4.15 7/15/2023470,000 shares $1.97 million -0.8%5.1%37 $4.19 6/30/2023474,000 shares $2.13 million +2.5%5.2%30.4 $4.49 6/15/2023462,500 shares $2.08 million -0.3%5.0%27.4 $4.50 5/31/2023464,000 shares $2.06 million -1.0%5.6%27.5 $4.45 5/15/2023468,800 shares $1.92 million +0.2%5.7%19.2 $4.10 4/30/2023467,700 shares $2.34 million -27.0%5.6%17.7 $5.00 4/15/2023640,800 shares $3.08 million -0.7%7.8%25.6 $4.80 3/31/2023645,600 shares $3.00 million +1.3%8.0%22.4 $4.64 3/15/2023637,400 shares $2.17 million +0.4%7.9%9.8 $3.40 2/28/2023635,000 shares $3.26 million +1.0%7.9%9.5 $5.13 2/15/2023628,500 shares $2.93 million -2.3%7.9%9 $4.66 1/31/2023643,000 shares $3.01 million +7.4%7.5%6.2 $4.68 1/15/2023598,500 shares $2.03 million +0.5%6.9%5.7 $3.40 12/30/2022595,300 shares $886,997.00 -0.2%6.9%5.8 $1.49 12/15/2022596,700 shares $948,753.00 -1.7%6.9%5.9 $1.59 11/30/2022606,700 shares $976,787.00 -3.0%7.1%8.9 $1.61 11/15/2022625,500 shares $1.22 million +2.0%7.0%9.4 $1.95 10/31/2022613,300 shares $1.84 million +0.3%7.0%25.1 $3.00 10/15/2022611,700 shares $1.93 million -1.0%7.0%23.3 $3.15 9/30/2022618,100 shares $2.32 million -0.6%20.6%23.1 $3.75 9/15/2022621,500 shares $2.52 million -1.1%20.7%14.2 $4.05Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NPCE Short Interest - Frequently Asked Questions What is NeuroPace's current short interest? Short interest is the volume of NeuroPace shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 89,800 shares of NPCE short. 0.65% of NeuroPace's shares are currently sold short. Learn More on NeuroPace's current short interest. What is a good short interest ratio for NeuroPace? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NPCE shares currently have a short interest ratio of 1.0. Learn More on NeuroPace's short interest ratio. What is a good short interest percentage for NeuroPace? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.65% of NeuroPace's floating shares are currently sold short. Is NeuroPace's short interest increasing or decreasing? NeuroPace saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 89,800 shares, a decline of 7.5% from the previous total of 97,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroPace's float size? NeuroPace currently has issued a total of 28,720,000 shares. Some of NeuroPace's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroPace currently has a public float of 13,740,000 shares. How does NeuroPace's short interest compare to its competitors? 0.65% of NeuroPace's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NeuroPace: Pulmonx Co. (4.01%), Anika Therapeutics, Inc. (5.64%), The Beauty Health Company (13.00%), Pulse Biosciences, Inc. (17.41%), Tactile Systems Technology, Inc. (5.64%), Cerus Co. (3.09%), Nevro Corp. (11.18%), OraSure Technologies, Inc. (4.90%), Surmodics, Inc. (3.63%), Sanara MedTech Inc. (4.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short NeuroPace stock? Short selling NPCE is an investing strategy that aims to generate trading profit from NeuroPace as its price is falling. NPCE shares are trading up $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroPace? A short squeeze for NeuroPace occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NPCE, which in turn drives the price of the stock up even further. How often is NeuroPace's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NPCE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LUNG Short Interest Data ANIK Short Interest Data SKIN Short Interest Data PLSE Short Interest Data TCMD Short Interest Data CERS Short Interest Data NVRO Short Interest Data OSUR Short Interest Data SRDX Short Interest Data SMTI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NPCE) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityHow Biden has already won 2024Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing